Table 1.
PDX | USI | Disease status | Ph-like ALL genomic lesions | ||
---|---|---|---|---|---|
CRLF2 | JAK | ABL class | |||
NH362 | PALTWS | D | IGH@-CRLF2* | ||
JH331 | PAMDKS | D | IGH@-CRLF2 | JAK2R683G | |
JH612 | PAMDRM | D | IGH@-CRLF2 | JAK2GPinsR683 | |
ALL121 | n/a | R | IGH@-CRLF2 | JAK2R683G | |
ALL4364 | PAWAKV | R | P2RY8-CRLF2 | JAK2R683G | |
JL491 | PAKMVD | D | JAK1S646F | ||
NL482A | PAKYEP | D | BCR-JAK2 | ||
NL432 | PAKKCA | D | EBF1-PDGFRB | ||
NH011 | PAKVKK | D | NUP214-ABL1 | ||
PHL3 | PANSFD | D | ETV6-ABL1 |
D, de novo; n/a, not available; R, relapse; USI, unique specimen identifier for primary patient sample.
Non–Ph-like by prediction analysis of microarrays.